INHIBIKASE THERAPEUTICS INC (IKT) Institutional Ownership and Insiders Activity

INHIBIKASE THERAPEUTICS INC (IKT) is widely held by institutional investors, with 1 tracked firm reporting positions valued at approximately $27,720 based on SEC Form 13F filings for the quarter ended March 31, 2026.

Renaissance Technologies LLC is the largest disclosed holder, reporting approximately $27,720 in IKT holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with Renaissance Technologies LLC representing the majority of disclosed value.